pipettes Search Results


jetprime in vitro dna transfection reagent  (Sartorius AG)
99
Sartorius AG jetprime in vitro dna transfection reagent
<t>Transfection,</t> cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Jetprime In Vitro Dna Transfection Reagent, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jetprime in vitro dna transfection reagent/product/Sartorius AG
Average 99 stars, based on 1 article reviews
jetprime in vitro dna transfection reagent - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier
multichannel pipette  (AutoMate Scientific Inc)
93
AutoMate Scientific Inc multichannel pipette
<t>Transfection,</t> cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Multichannel Pipette, supplied by AutoMate Scientific Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multichannel pipette/product/AutoMate Scientific Inc
Average 93 stars, based on 1 article reviews
multichannel pipette - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
single channel micropipets  (Eppendorf AG)
93
Eppendorf AG single channel micropipets
<t>Transfection,</t> cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Single Channel Micropipets, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/single channel micropipets/product/Eppendorf AG
Average 93 stars, based on 1 article reviews
single channel micropipets - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
pipette  (Gilson Inc)
92
Gilson Inc pipette
<t>Transfection,</t> cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Pipette, supplied by Gilson Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pipette/product/Gilson Inc
Average 92 stars, based on 1 article reviews
pipette - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
sterile serological pipettes  (Greiner Bio)
92
Greiner Bio sterile serological pipettes
<t>Transfection,</t> cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Sterile Serological Pipettes, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sterile serological pipettes/product/Greiner Bio
Average 92 stars, based on 1 article reviews
sterile serological pipettes - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
pipette tip  (Greiner Bio)
93
Greiner Bio pipette tip
<t>Transfection,</t> cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Pipette Tip, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pipette tip/product/Greiner Bio
Average 93 stars, based on 1 article reviews
pipette tip - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
serological pipettes  (Greiner Bio)
93
Greiner Bio serological pipettes
<t>Transfection,</t> cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Serological Pipettes, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/serological pipettes/product/Greiner Bio
Average 93 stars, based on 1 article reviews
serological pipettes - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
pvc serum pipettes  (Greiner Bio)
92
Greiner Bio pvc serum pipettes
<t>Transfection,</t> cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Pvc Serum Pipettes, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pvc serum pipettes/product/Greiner Bio
Average 92 stars, based on 1 article reviews
pvc serum pipettes - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
handystep electronic repeating pipette  (BrandTech)
93
BrandTech handystep electronic repeating pipette
<t>Transfection,</t> cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Handystep Electronic Repeating Pipette, supplied by BrandTech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/handystep electronic repeating pipette/product/BrandTech
Average 93 stars, based on 1 article reviews
handystep electronic repeating pipette - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
greiner cat  (Greiner Bio)
92
Greiner Bio greiner cat
<t>Transfection,</t> cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Greiner Cat, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/greiner cat/product/Greiner Bio
Average 92 stars, based on 1 article reviews
greiner cat - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
disposable serological pipettes  (Greiner Bio)
93
Greiner Bio disposable serological pipettes
<t>Transfection,</t> cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Disposable Serological Pipettes, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/disposable serological pipettes/product/Greiner Bio
Average 93 stars, based on 1 article reviews
disposable serological pipettes - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
pipette tips  (Greiner Bio)
93
Greiner Bio pipette tips
<t>Transfection,</t> cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Pipette Tips, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pipette tips/product/Greiner Bio
Average 93 stars, based on 1 article reviews
pipette tips - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

Image Search Results


Transfection, cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Journal: Vaccines

Article Title: A Precision-Engineered DC-Targeting mRNA-LNP Neoantigen Vaccine Elicits Stronger T Cell Responses and Exhibits Superior Tumor Control

doi: 10.3390/vaccines14030239

Figure Lengend Snippet: Transfection, cytotoxicity, and biodistribution of mRNA-LNP complexes. ( A ) Cytotoxicity of Mal-LNP and Nb-LNP in mCLEC9A + HEK-293T cells. Cell viability evaluated using Cell Titer Luminescent Cell Viability Assay kit 24 h after treatment with mRNA Mal-LNP or Nb-LNP. ( B , C ) Time-course quantification of bioluminescence resulted from treating mCLEC9A + HEK-293T cells and FL-DCs derived from mouse bone marrow with mRNA Mal-LNP or Nb-LNP at 0.5 μg/mL ( n = 5). ( D ) Ex vivo imaging of organs was performed 4 h after injection. Shown are representative bioluminescence images and quantification of bioluminescence signals from organs extracted from C57BL/6 mice following intramuscular administration of 5 μg luciferase (Luc) formulated in either Mal-LNP or Nb-LNP. Abbreviations: LN, lymph node; Li, liver; S, spleen; Lu, lung; K, kidney. ( E , F ) Quantification of eGFP + cells in distinct cell subsets in spleen and lymph nodes 36 h after mice were treated intramuscularly with 10 μg eGFP mRNA-LNP. Statistical analyses were performed using two-way ANOVA. All results are presented as mean ± SEM. “ns”, no significant difference; * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Article Snippet: The transfection procedure was facilitated using the JetPRIME in vitro DNA Transfection Reagent (CAT.101000046 (114-15), Polyplus, Strasbourg, France).

Techniques: Transfection, Cell Viability Assay, Derivative Assay, Ex Vivo, Imaging, Injection, Luciferase